5 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Compared to Estimates, Baxter (BAX) Q1 Earnings: A Look at Key Metrics https://www.zacks.com/stock/news/2267248/compared-to-estimates-baxter-bax-q1-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2267248 May 02, 2024 - Although the revenue and EPS for Baxter (BAX) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
What's in Store for These 5 Medical Device Stocks in Q1 Earnings? https://www.zacks.com/stock/news/2266269/what-s-in-store-for-these-5-medical-device-stocks-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2266269 May 01, 2024 - Here is a sneak peek into how five medical device stocks, BDX, BAX, XRAY, CAH and DVA, might fare in their quarterly results slated to be released tomorrow.
Baxter's (BAX) New Injectables Aid Its Pharmaceutical Portfolio https://www.zacks.com/stock/news/2254665/baxter-s-bax-new-injectables-aid-its-pharmaceutical-portfolio?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2254665 Apr 12, 2024 - Baxter (BAX) unveils its five injectable products, which strengthen its emphasis on unique products and expand the pharmaceutical portfolio of the business in important therapeutic areas.
3 Medical Device Stocks With Solid Dividend Yield: CAH & Others https://www.zacks.com/stock/news/2253901/3-medical-device-stocks-with-solid-dividend-yield-cah-others?cid=CS-ZC-FT-analyst_blog|industry_focus-2253901 Apr 11, 2024 - Here we discuss three medical device stocks, Cardinal Health (CAH), Baxter International (BAX) and Fresenius Medical Care (FMS), with a solid five-year dividend growth history.
Countdown to Baxter (BAX) Q4 Earnings: Wall Street Forecasts for Key Metrics https://www.zacks.com/stock/news/2220901/countdown-to-baxter-bax-q4-earnings-wall-street-forecasts-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2220901 Feb 05, 2024 - Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Baxter (BAX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.

Pages: 1

Page 1